ResMed Inc
NYSE:RMD
$ 183.78
$-0.44 (-0.24%)
$ 183.78
$-0.44 (-0.24%)
End-of-day quote: 04/24/2024

RMD - ResMed Inc Stock Prediction 2025 - 2030

20 years of reliable ResMed Inc stock forecast. The Wall Street analysts predict Outperform for RMD. See at a glance whether NYSE:RMD will rise in the future.

$228.36
Forecast 2023
$296.80
Forecast 2025
$333.47
Forecast 2030
Outperform
TopGraphs Quality Ranking
Forecast 2023
$228.36
Forecast 2025
$296.80
Forecast 2030
$333.47
TopGraphs Quality Ranking
Outperform

Company Info

P/E
0.00
Beta
0.67
Price-to-book Ratio
6.03
Market Cap
26.27B
TEV
28.59 B
Dividend
$1.91
Div Yld
1.04%
Forecast 1Y
44.17%
Forecast 2Y
59.33%
Analyst Price Target
$201.32
Website

ResMed Inc Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

ResMed Inc Stock Forecast 2023

$205.00

In the last five quarters, ResMed Inc’s Price Target has fallen from $246.32 to $201.32 - a -18.27% decrease. Thridteen analysts predict that ResMed Inc’s share price will increase in the coming year, reaching $205.00. This would represent an increase of 1.83%.

11.55%
11.55
Last update: 04/25/2024

Highest Price Target $258.00

Average Price Target $205.00

Lowest Price Target $164.00

ResMed Inc Stock Prediction 2025

ResMed Inc Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $288.53. An increase of 57% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $290.18. An increase of 57.9% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $291.84. An increase of 58.8% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $293.49. An increase of 59.7% compared to the previous month's estimate.

ResMed Inc Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $295.15. An increase of 60.6% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $296.80. An increase of 61.5% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $299.25. An increase of 62.83% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $301.71. An increase of 64.17% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $304.16. An increase of 65.5% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $306.61. An increase of 66.84% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $309.06. An increase of 68.17% compared to the previous month's estimate.

ResMed Inc Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $311.52. An increase of 69.5% compared to the previous month's estimate.

ResMed Inc Stock Forecast 2030

Stock Forecast for the Price of an ResMed Inc Share in Jan 2030.

In January 2030, analysts believe the stock price will be $334.21. An increase of 81.85% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Feb 2030.

In February 2030, analysts believe the stock price will be $334.06. An increase of 81.77% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Mar 2030.

In March 2030, analysts believe the stock price will be $333.91. An increase of 81.69% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Apr 2030.

In April 2030, analysts believe the stock price will be $333.77. An increase of 81.61% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in May 2030.

In May 2030, analysts believe the stock price will be $333.62. An increase of 81.53% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Jun 2030.

In June 2030, analysts believe the stock price will be $333.47. An increase of 81.45% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Jul 2030.

In July 2030, analysts believe the stock price will be $334.53. An increase of 82.03% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Aug 2030.

In August 2030, analysts believe the stock price will be $335.59. An increase of 82.6% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Sep 2030.

In September 2030, analysts believe the stock price will be $336.64. An increase of 83.18% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Oct 2030.

In October 2030, analysts believe the stock price will be $337.70. An increase of 83.75% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Nov 2030.

In November 2030, analysts believe the stock price will be $338.76. An increase of 84.33% compared to the previous month's estimate.

Stock Forecast for the Price of an ResMed Inc Share in Dec 2030.

In December 2030, analysts believe the stock price will be $339.81. An increase of 84.9% compared to the previous month's estimate.

P/E
0.00
Beta
0.67
Price-to-book Ratio
6.03
Market Cap
26.27B
TEV
28.59 B
Dividend
$1.91
Div Yld
1.04%
Forecast 1Y
44.17%
Forecast 2Y
59.33%
Analyst Price Target
$201.32
Website

ResMed Inc Analyst Ratings Frequently Asked Questions

Who are the analysts watching ResMed Inc?

The following analysts have recently covered ResMed Inc:

Barrenjoey Markets Pty Limited
BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
CLSA
J.P. Morgan
Jarden Limited
Macquarie Research
Marktfeld
Morgan Stanley
Morgans Financial Limited
Morningstar Inc.
Needham & Company
Oppenheimer & Co. Inc.
RBC Capital Markets
William Blair & Company L.L.C.
Wilsons Advisory and Stockbroking Ltd.
Wolfe Research, LLC.
Baptista Research
Jefferies LLC
Mizuho Securities USA LLC
UBS Investment Bank
Equisights
(This information refers to the last 90 days.)

Who are the sell-side analysts watching ResMed Inc?

The following sell-side analysts have recently covered ResMed Inc:

Polark, Michael K.
Hadassin, Saul
Harrison, Lyanne
Jellinek, Derek
Low, David A.
Wheen, Steven David
Bailey, David
Paraskevopoulos, Michail
Laaman, Sean M.
Ponraj, Shane
Matson, Michael Stephen
Kalia, Suraj
Wong-Pan, Craig
Kaczor Andrew, Malgorzata Maria
Storey, Shane A.
Chevrier, Mathieu
Majumdar, Ishan
Miller, Matthew
Taylor, Matthew Charles
Petrone, Anthony Charles
Sutcliffe, Laura
Talsania, Parth
Paine, Andrew
(This information refers to the last 90 days.)